Guru Ownership Trend
Guru Analysis for Heron Therapeutics, Inc. (HRTX)
Heron Therapeutics, Inc. (HRTX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $2.03 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $54,156.45 net inflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 70.5%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 10.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Heron Therapeutics, Inc. (HRTX)
Major holders include Renaissance Technologies (RenTech) ($1.37 M), Cliff Asness ($513,334). According to the latest reported data, 2 tracked investment managers collectively hold approximately 2.36 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $54,156.45, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited HRTX. The total reported sell value was $158,099.78.
Yes, 0 managers opened new positions in HRTX, and 1 increased their existing holdings. The total reported buy value was $212,256.23.